← Back to headlines
Merck and Kelun Lung Cancer Drug Shows Superiority
A combination therapy for lung cancer developed by Merck and Kelun has demonstrated better results than Keytruda in a late-stage clinical trial.
22 May, 12:12 — 22 May, 12:12
Sources
Showing 1 of 1 sources
Related Stories
Hayden Panettiere's Health Struggles Before Her Death Revealed
1h ago
Airline Pilots Face Highest Cancer Risk from Radiation Exposure
1h ago
Study Reveals Elderly More Vulnerable to Extreme Heat Than Previously Thought
4h ago
Nollywood Actor Ogogo Hassan's Daughters Seek Help for Father's Stage 4 Cancer
8h ago